Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check2 days agoChange DetectedThe study has expanded to 167 locations and is now actively recruiting, with several new sites added across the United States and Europe, including notable institutions like Stanford University School of Medicine and various clinical research centers.SummaryDifference14%
- Check9 days agoChange DetectedThe study has expanded to include 166 locations, with several new sites added in Bulgaria, Czechia, and Japan, while 155 locations have been removed, indicating a significant update in the study's scope.SummaryDifference12%
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe website has added numerous new contact entries for various sites, including specific contacts with phone numbers, while the previous version and type of intervention have been removed.SummaryDifference17%
- Check52 days agoChange DetectedNew recruiting sites have been added for the State Psychiatric Hospital Sv. Ivan Rilski and Medical Center Medconsult Pleven, while previous non-recruiting sites have been removed, indicating a shift towards active recruitment.SummaryDifference1%
- Check59 days agoChange DetectedThe website has updated its contact details for the study, now listing new contacts and locations, and has changed the recruitment status to 'Recruiting', while removing previous contact information and status.SummaryDifference3%
Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.